{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:02:52Z","timestamp":1763179372250},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00347-022-01609-3","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:17:20Z","timestamp":1648819040000},"page":"425-438","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sekund\u00e4re Offenwinkelglaukome: Pseudoexfoliationsglaukom, Pigmentglaukom und Neovaskularisationsglaukom"],"prefix":"10.1007","volume":"119","author":[{"given":"Roman","family":"Greslechner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Horst","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlev","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"1609_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2021-egsguidelines","volume":"105","author":"EGS","year":"2021","unstructured":"EGS (2021) European glaucoma society terminology and guidelines for glaucoma, 5th edition. Br J Ophthalmol 105:1\u2013169. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines","journal-title":"Br J Ophthalmol"},{"key":"1609_CR2","doi-asserted-by":"publisher","first-page":"107818","DOI":"10.1016\/j.exer.2019.107818","volume":"189","author":"U Schl\u00f6tzer-Schrehardt","year":"2019","unstructured":"Schl\u00f6tzer-Schrehardt\u00a0U, Zenkel\u00a0M (2019) The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma. Exp Eye Res 189:107818. https:\/\/doi.org\/10.1016\/j.exer.2019.107818","journal-title":"Exp Eye Res"},{"key":"1609_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1600-0420.1997.tb00767.x","volume":"75","author":"A Ringvold","year":"1997","unstructured":"Ringvold\u00a0A, Blika\u00a0S, Sandvik\u00a0L (1997) Pseudoexfoliation and mortality. Acta Ophthalmol Scand 75:255\u2013256. https:\/\/doi.org\/10.1111\/j.1600-0420.1997.tb00767.x","journal-title":"Acta Ophthalmol Scand"},{"key":"1609_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0002-9394(99)00255-x","volume":"129","author":"KR Shrum","year":"2000","unstructured":"Shrum\u00a0KR, Hattenhauer\u00a0MG, Hodge\u00a0D (2000) Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation. Am J Ophthalmol 129:83\u201386. https:\/\/doi.org\/10.1016\/s0002-9394(99)00255-x","journal-title":"Am J Ophthalmol"},{"key":"1609_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/s0002-9394(14)70908-0","volume":"124","author":"P Mitchell","year":"1997","unstructured":"Mitchell\u00a0P, Wang\u00a0JJ, Smith\u00a0W (1997) Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 124:685\u2013687. https:\/\/doi.org\/10.1016\/s0002-9394(14)70908-0","journal-title":"Am J Ophthalmol"},{"key":"1609_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/00061198-200306000-00002","volume":"12","author":"RA Karger","year":"2003","unstructured":"Karger\u00a0RA, Jeng\u00a0SM, Johnson\u00a0DH et\u00a0al (2003) Estimated incidence of pseudoexfoliation syndrome and pseudoexfoliation glaucoma in Olmsted County, Minnesota. J\u00a0Glaucoma 12:193\u2013197. https:\/\/doi.org\/10.1097\/00061198-200306000-00002","journal-title":"J Glaucoma"},{"key":"1609_CR7","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/00061198-200212000-00012","volume":"11","author":"PM Puska","year":"2002","unstructured":"Puska\u00a0PM (2002) Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma: a\u00a0prospective 10-year follow-up study. J\u00a0Glaucoma 11:517\u2013524. https:\/\/doi.org\/10.1097\/00061198-200212000-00012","journal-title":"J Glaucoma"},{"key":"1609_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1755-3768.1993.tb04989.x","volume":"71","author":"C Ekstr\u00f6m","year":"1993","unstructured":"Ekstr\u00f6m\u00a0C (1993) Elevated intraocular pressure and pseudoexfoliation of the lens capsule as risk factors for chronic open-angle glaucoma. Acta Ophthalmol 71:189\u2013195. https:\/\/doi.org\/10.1111\/j.1755-3768.1993.tb04989.x","journal-title":"Acta Ophthalmol"},{"key":"1609_CR9","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/archopht.117.10.1319","volume":"117","author":"P Mitchell","year":"1999","unstructured":"Mitchell\u00a0P, Wang\u00a0JJ, Hourihan\u00a0F (1999) The relationship between glaucoma and pseudoexfoliation: the blue mountains eye study. Arch Ophthalmol 117:1319\u20131324. https:\/\/doi.org\/10.1001\/archopht.117.10.1319","journal-title":"Arch Ophthalmol"},{"key":"1609_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ajo.2009.03.024","volume":"148","author":"F Topouzis","year":"2009","unstructured":"Topouzis\u00a0F, Harris\u00a0A, Wilson\u00a0MR et\u00a0al (2009) Increased likelihood of glaucoma at the same screening intraocular pressure in subjects with pseudoexfoliation: the Thessaloniki eye study. Am J Ophthalmol 148:606\u2013613.e1. https:\/\/doi.org\/10.1016\/j.ajo.2009.03.024","journal-title":"Am J Ophthalmol"},{"key":"1609_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0039-6257(00)00196-x","volume":"45","author":"R Ritch","year":"2001","unstructured":"Ritch\u00a0R, Schl\u00f6tzer-Schrehardt\u00a0U (2001) Exfoliation syndrome. Surv Ophthalmol 45:265\u2013315. https:\/\/doi.org\/10.1016\/s0039-6257(00)00196-x","journal-title":"Surv Ophthalmol"},{"key":"1609_CR12","first-page":"148","volume":"3","author":"H Helbig","year":"1994","unstructured":"Helbig\u00a0H, Schl\u00f6tzer-Schrehardt\u00a0U, Noske\u00a0W et al (1994) Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 3:148\u2013153","journal-title":"Ger J Ophthalmol"},{"key":"1609_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/bjo.2006.106690","volume":"91","author":"AGP Konstas","year":"2007","unstructured":"Konstas\u00a0AGP, Holl\u00f3\u00a0G, Irkec\u00a0M et al (2007) Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a\u00a0crossover, observer-masked, three-centre study. Br J Ophthalmol 91:757. https:\/\/doi.org\/10.1136\/bjo.2006.106690","journal-title":"Br J Ophthalmol"},{"key":"1609_CR14","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1097\/ijg.0000000000000909","volume":"27","author":"S Sandhu","year":"2018","unstructured":"Sandhu\u00a0S, Damji\u00a0KF (2018) Laser management of glaucoma in exfoliation syndrome. J\u00a0Glaucoma 27:S91\u2013S94. https:\/\/doi.org\/10.1097\/ijg.0000000000000909","journal-title":"J Glaucoma"},{"key":"1609_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.2147\/opth.s77570","volume":"9","author":"G Holl\u00f3","year":"2015","unstructured":"Holl\u00f3\u00a0G, Katsanos\u00a0A, Konstas\u00a0A\u2011G (2015) Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol 9:907\u2013919. https:\/\/doi.org\/10.2147\/opth.s77570","journal-title":"Clin Ophthalmol"},{"key":"1609_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1055\/s-2008-1034715","volume":"215","author":"S Serguhn","year":"1999","unstructured":"Serguhn\u00a0S, Spiegel\u00a0D (1999) Vergleich des postoperativen Verlaufes nach Trabekulektomie bei Pseudoexfoliationsglaukom und prim\u00e4rem chronischen Offenwinkelglaukom. Klin Monbl Augenheilkd 215:281\u2013286. https:\/\/doi.org\/10.1055\/s-2008-1034715","journal-title":"Klin Monbl Augenheilkd"},{"key":"1609_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1442-9071.2002.00513.x","volume":"30","author":"WE Gillies","year":"2002","unstructured":"Gillies\u00a0WE, Brooks\u00a0AM (2002) Central retinal vein occlusion in pseudoexfoliation of the lens capsule. Clin Exp Ophthalmol 30:176\u2013187. https:\/\/doi.org\/10.1046\/j.1442-9071.2002.00513.x","journal-title":"Clin Exp Ophthalmol"},{"key":"1609_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s10792-020-01668-y","volume":"41","author":"N Tojo","year":"2021","unstructured":"Tojo\u00a0N, Hayashi\u00a0A (2021) Ex-Press\u00ae versus Baerveldt implant surgery for primary open-angle glaucoma and pseudo-exfoliation glaucoma. Int Ophthalmol 41:1091\u20131101. https:\/\/doi.org\/10.1007\/s10792-020-01668-y","journal-title":"Int Ophthalmol"},{"key":"1609_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1755-3768.2009.01772.x","volume":"89","author":"ML Ollikainen","year":"2011","unstructured":"Ollikainen\u00a0ML, Puustj\u00e4rvi\u00a0TJ, Rekonen\u00a0PK et al (2011) Mitomycin C\u2011augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a\u00a0three-year prospective study. Acta Ophthalmol 89:548\u2013555. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01772.x","journal-title":"Acta Ophthalmol"},{"key":"1609_CR20","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00417-016-3370-6","volume":"254","author":"A-M Seuthe","year":"2016","unstructured":"Seuthe\u00a0A\u2011M, Ivanescu\u00a0C, Leers\u00a0S et al (2016) Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty\u20141-year results. Graefes Arch Clin Exp Ophthalmol 254:1591\u20131597. https:\/\/doi.org\/10.1007\/s00417-016-3370-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1609_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02713683.2020.1795203","volume":"46","author":"A-M Seuthe","year":"2020","unstructured":"Seuthe\u00a0A\u2011M, Szurman\u00a0P, Januschowski\u00a0K (2020) Canaloplasty with suprachoroidal drainage in patients with pseudoexfoliation glaucoma\u2014four years results. Curr Eye Res 46:1\u20137. https:\/\/doi.org\/10.1080\/02713683.2020.1795203","journal-title":"Curr Eye Res"},{"key":"1609_CR22","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/s0886-3350(01)00972-5","volume":"27","author":"P Puska","year":"2001","unstructured":"Puska\u00a0P, Tarkkanen\u00a0A (2001) Exfoliation syndrome as a\u00a0risk factor for cataract development five-year follow-up of lens opacities in exfoliation syndrome. J\u00a0Cataract Refract Surg 27:1992\u20131998. https:\/\/doi.org\/10.1016\/s0886-3350(01)00972-5","journal-title":"J Cataract Refract Surg"},{"key":"1609_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1755-3768.1987.tb07021.x","volume":"65","author":"J Ruotsalainen","year":"1987","unstructured":"Ruotsalainen\u00a0J, Tarkkanen\u00a0A (1987) Capsule thickness of cataractous lenses with and without exfoliation syndrome. Acta Ophthalmol 65:444\u2013449. https:\/\/doi.org\/10.1111\/j.1755-3768.1987.tb07021.x","journal-title":"Acta Ophthalmol"},{"key":"1609_CR24","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/s0161-6420(01)00710-2","volume":"108","author":"FS Jehan","year":"2001","unstructured":"Jehan\u00a0FS, Mamalis\u00a0N, Crandall\u00a0AS (2001) Spontaneous late dislocation of intraocular lens within the capsular bag in pseudoexfoliation patients. Ophthalmology 108:1727\u20131731. https:\/\/doi.org\/10.1016\/s0161-6420(01)00710-2","journal-title":"Ophthalmology"},{"key":"1609_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/bjo.2006.091447","volume":"90","author":"KF Damji","year":"2006","unstructured":"Damji\u00a0KF, Konstas\u00a0AGP, Liebmann\u00a0JM et\u00a0al (2006) Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a\u00a02\u00a0year prospective study. Br J Ophthalmol 90:1014. https:\/\/doi.org\/10.1136\/bjo.2006.091447","journal-title":"Br J Ophthalmol"},{"key":"1609_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/aos.12945","volume":"94","author":"O Kristianslund","year":"2016","unstructured":"Kristianslund\u00a0O, \u00d8stern\u00a0AE, R\u00e5en\u00a0M et al (2016) Does cataract surgery reduce the long-term risk of glaucoma in eyes with pseudoexfoliation syndrome? Acta Ophthalmol 94:261\u2013265. https:\/\/doi.org\/10.1111\/aos.12945","journal-title":"Acta Ophthalmol"},{"key":"1609_CR27","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/s0161-6420(98)95032-1","volume":"105","author":"PC Jacobi","year":"1998","unstructured":"Jacobi\u00a0PC, Dietlein\u00a0TS, Krieglstein\u00a0GK (1998) Bimanual trabecular aspiration in pseudoexfoliation glaucoma an alternative in nonfiltering glaucoma surgery. Ophthalmology 105:886\u2013894. https:\/\/doi.org\/10.1016\/s0161-6420(98)95032-1","journal-title":"Ophthalmology"},{"key":"1609_CR28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/j.jcrs.0000000000000243","volume":"46","author":"TJ Ferguson","year":"2020","unstructured":"Ferguson\u00a0TJ, Swan\u00a0RJ, Bleeker\u00a0A et al (2020) Trabecular microbypass stent implantation in pseudoexfoliative glaucoma: long-term results. J\u00a0Cataract Refract Surg 46:1284\u20131289. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000000243","journal-title":"J Cataract Refract Surg"},{"key":"1609_CR29","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1055\/s-0041-105941","volume":"232","author":"M Pahlitzsch","year":"2015","unstructured":"Pahlitzsch\u00a0M, Gonnermann\u00a0J, Maier\u00a0A\u2011K et al (2015) Trabekulotomie ab interno (Trabectome) \u2013 Kumulierte klinische Ergebnisse eines gro\u00dfen Glaukomkollektivs. Klin Monbl Augenheilkd 232:1198\u20131207. https:\/\/doi.org\/10.1055\/s-0041-105941","journal-title":"Klin Monbl Augenheilkd"},{"key":"1609_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.18240\/ijo.2020.06.13","volume":"13","author":"K Iwasaki","year":"2020","unstructured":"Iwasaki\u00a0K, Takamura\u00a0Y, Orii\u00a0Y et\u00a0al (2020) Performances of glaucoma operations with Kahook dual blade or iStent combined with phacoemulsification in Japanese open angle glaucoma patients. Int J Ophthalmol 13:941\u2013945. https:\/\/doi.org\/10.18240\/ijo.2020.06.13","journal-title":"Int J Ophthalmol"},{"key":"1609_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/s0002-9394(02)02289-4","volume":"135","author":"Y Siddiqui","year":"2003","unstructured":"Siddiqui\u00a0Y, Hulzen\u00a0RDT, Cameron\u00a0JD et\u00a0al (2003) What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 135:794\u2013799. https:\/\/doi.org\/10.1016\/s0002-9394(02)02289-4","journal-title":"Am J Ophthalmol"},{"key":"1609_CR32","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s10792-018-0938-7","volume":"39","author":"G Scuderi","year":"2019","unstructured":"Scuderi\u00a0G, Contestabile\u00a0MT, Scuderi\u00a0L et\u00a0al (2019) Pigment dispersion syndrome and pigmentary glaucoma: a\u00a0review and update. Int Ophthalmol 39:1651\u20131662. https:\/\/doi.org\/10.1007\/s10792-018-0938-7","journal-title":"Int Ophthalmol"},{"key":"1609_CR33","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1442-9071.2009.01920.x","volume":"36","author":"N Niyadurupola","year":"2008","unstructured":"Niyadurupola\u00a0N, Broadway\u00a0DC (2008) Pigment dispersion syndrome and pigmentary glaucoma\u2014a\u00a0major review. Clin Exp Ophthalmol 36:868\u2013882. https:\/\/doi.org\/10.1111\/j.1442-9071.2009.01920.x","journal-title":"Clin Exp Ophthalmol"},{"key":"1609_CR34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3928\/1542-8877-19920401-11","volume":"23","author":"JR Karickhoff","year":"1992","unstructured":"Karickhoff\u00a0JR (1992) Pigmentary dispersion syndrome and pigmentary glaucoma: a\u00a0new mechanism concept, a\u00a0new treatment, and a\u00a0new technique. Ophthalmic Surg Lasers Imaging Retina 23:269\u2013277. https:\/\/doi.org\/10.3928\/1542-8877-19920401-11","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"1609_CR35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/archopht.117.3.325","volume":"117","author":"PJ Breingan","year":"1999","unstructured":"Breingan\u00a0PJ, Esaki\u00a0K, Ishikawa\u00a0H et\u00a0al (1999) Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol 117:325\u2013328. https:\/\/doi.org\/10.1001\/archopht.117.3.325","journal-title":"Arch Ophthalmol"},{"key":"1609_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00055735-199704000-00007","volume":"8","author":"N Gupta","year":"1997","unstructured":"Gupta\u00a0N, Weinreb\u00a0RN (1997) New definitions of glaucoma. Curr Opin Ophthalmol 8:38\u201341. https:\/\/doi.org\/10.1097\/00055735-199704000-00007","journal-title":"Curr Opin Ophthalmol"},{"key":"1609_CR37","first-page":"984","volume":"74","author":"PR Lichter","year":"1970","unstructured":"Lichter\u00a0PR, Shaffer\u00a0RN (1970) Diagnostic and prognostic signs in pigmentary glaucoma. Trans Am Acad Ophthalmol Otolaryngol 74:984\u2013998","journal-title":"Trans Am Acad Ophthalmol Otolaryngol"},{"key":"1609_CR38","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/s0161-6420(93)31555-1","volume":"100","author":"R Ritch","year":"1993","unstructured":"Ritch\u00a0R, Liebmann\u00a0J, Robin\u00a0A et\u00a0al (1993) Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology 100:909\u2013913. https:\/\/doi.org\/10.1016\/s0161-6420(93)31555-1","journal-title":"Ophthalmology"},{"key":"1609_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/ijg.0b013e318287abb7","volume":"23","author":"M Ayala","year":"2014","unstructured":"Ayala\u00a0M (2014) Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. J\u00a0Glaucoma 23:616\u2013619. https:\/\/doi.org\/10.1097\/ijg.0b013e318287abb7","journal-title":"J Glaucoma"},{"key":"1609_CR40","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ajo.2004.11.038","volume":"139","author":"PJ Harasymowycz","year":"2005","unstructured":"Harasymowycz\u00a0PJ, Papamatheakis\u00a0DG, Latina\u00a0M et\u00a0al (2005) Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. Am J Ophthalmol 139:1110\u20131113. https:\/\/doi.org\/10.1016\/j.ajo.2004.11.038","journal-title":"Am J Ophthalmol"},{"key":"1609_CR41","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/icu.0000000000000352","volume":"28","author":"K Okafor","year":"2017","unstructured":"Okafor\u00a0K, Vinod\u00a0K, Gedde\u00a0SJ (2017) Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 28:154\u2013160. https:\/\/doi.org\/10.1097\/icu.0000000000000352","journal-title":"Curr Opin Ophthalmol"},{"key":"1609_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00417-009-1262-8","volume":"248","author":"VJ Setlur","year":"2010","unstructured":"Setlur\u00a0VJ, Parikh\u00a0JG, Rao\u00a0NA (2010) Changing causes of enucleation over the past 60\u00a0years. Graefes Arch Clin Exp Ophthalmol 248:593\u2013597. https:\/\/doi.org\/10.1007\/s00417-009-1262-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1609_CR43","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000431196","volume":"55","author":"SJ Havens","year":"2015","unstructured":"Havens\u00a0SJ, Gulati\u00a0V (2015) Neovascular glaucoma. Dev Ophthalmol 55:196\u2013204. https:\/\/doi.org\/10.1159\/000431196","journal-title":"Dev Ophthalmol"},{"key":"1609_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09286586.2020.1755445","volume":"27","author":"P-A Lin","year":"2020","unstructured":"Lin\u00a0P\u2011A, Lee\u00a0C\u2011Y, Huang\u00a0F\u2011C et al (2020) Trend of neovascular nlaucoma in Taiwan: a\u00a015-year nationwide population-based cohort study. Ophthalmic Epidemiol 27:1\u20139. https:\/\/doi.org\/10.1080\/09286586.2020.1755445","journal-title":"Ophthalmic Epidemiol"},{"key":"1609_CR45","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/s0161-6420(98)95014-x","volume":"105","author":"DJ Browning","year":"1998","unstructured":"Browning\u00a0DJ, Scott\u00a0AQ, Peterson\u00a0CB et\u00a0al (1998) The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 105:776\u2013784. https:\/\/doi.org\/10.1016\/s0161-6420(98)95014-x","journal-title":"Ophthalmology"},{"key":"1609_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/s0002-9394(14)72173-7","volume":"120","author":"KJ Blinder","year":"1995","unstructured":"Blinder\u00a0KJ, Friedman\u00a0SM, Mames\u00a0RN (1995) Diabetic iris neovascularization. Am J Ophthalmol 120:393\u2013395. https:\/\/doi.org\/10.1016\/s0002-9394(14)72173-7","journal-title":"Am J Ophthalmol"},{"key":"1609_CR47","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archopht.1993.01090080083022","volume":"111","author":"No authors listed","year":"1993","unstructured":"No authors listed (1993) Baseline and early natural history report: the central vein occlusion study. Arch Ophthalmol 111:1087\u20131095. https:\/\/doi.org\/10.1001\/archopht.1993.01090080083022","journal-title":"Arch Ophthalmol"},{"key":"1609_CR48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/s0161-6420(80)35225-1","volume":"87","author":"W Tasman","year":"1980","unstructured":"Tasman\u00a0W, Magargal\u00a0LE, Augsburger\u00a0JJ (1980) Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 87:400\u2013402. https:\/\/doi.org\/10.1016\/s0161-6420(80)35225-1","journal-title":"Ophthalmology"},{"key":"1609_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/archopht.1967.00980020487011","volume":"77","author":"MF Armaly","year":"1967","unstructured":"Armaly\u00a0MF, Baloglou\u00a0PJ (1967) Diabetes mellitus and the eye: 1. Changes in the anterior segment. Arch Ophthalmol 77:485\u2013492. https:\/\/doi.org\/10.1001\/archopht.1967.00980020487011","journal-title":"Arch Ophthalmol"},{"key":"1609_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1136\/bjo.55.7.444","volume":"55","author":"PH Madsen","year":"1971","unstructured":"Madsen\u00a0PH (1971) Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients. Br J Ophthalmol 55:444\u2013450. https:\/\/doi.org\/10.1136\/bjo.55.7.444","journal-title":"Br J Ophthalmol"},{"key":"1609_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1755-3768.1971.tb00954.x","volume":"49","author":"V Ohrt","year":"1971","unstructured":"Ohrt\u00a0V (1971) The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol 49:301\u2013307. https:\/\/doi.org\/10.1111\/j.1755-3768.1971.tb00954.x","journal-title":"Acta Ophthalmol"},{"key":"1609_CR52","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1755-3768.1983.tb04357.x","volume":"61","author":"NV Nielsen","year":"1983","unstructured":"Nielsen\u00a0NV (1983) The prevanlence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol 61:662\u2013672. https:\/\/doi.org\/10.1111\/j.1755-3768.1983.tb04357.x","journal-title":"Acta Ophthalmol"},{"key":"1609_CR53","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/112067211002000603","volume":"20","author":"AK Rudkin","year":"2010","unstructured":"Rudkin\u00a0AK, Lee\u00a0AW, Chen\u00a0CS (2010) Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 20:1042\u20131046. https:\/\/doi.org\/10.1177\/112067211002000603","journal-title":"Eur J Ophthalmol"},{"key":"1609_CR54","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0002-9394(76)90123-9","volume":"81","author":"JR Neupert","year":"1976","unstructured":"Neupert\u00a0JR, Brubaker\u00a0RF, Kearns\u00a0TP et\u00a0al (1976) Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 81:600\u2013602. https:\/\/doi.org\/10.1016\/0002-9394(76)90123-9","journal-title":"Am J Ophthalmol"},{"key":"1609_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/bf00184005","volume":"232","author":"Y Ohnishi","year":"1994","unstructured":"Ohnishi\u00a0Y, Ishibashi\u00a0T, Sagawa\u00a0T (1994) Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 232:199\u2013204. https:\/\/doi.org\/10.1007\/bf00184005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1609_CR56","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/icu.0b013e3283360aad","volume":"21","author":"MB Horsley","year":"2010","unstructured":"Horsley\u00a0MB, Kahook\u00a0MY (2010) Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol 21:112\u2013117. https:\/\/doi.org\/10.1097\/icu.0b013e3283360aad","journal-title":"Curr Opin Ophthalmol"},{"key":"1609_CR57","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.ophtha.2008.02.026","volume":"115","author":"T Wakabayashi","year":"2008","unstructured":"Wakabayashi\u00a0T, Oshima\u00a0Y, Sakaguchi\u00a0H et\u00a0al (2008) Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41\u00a0consecutive cases. Ophthalmology 115:1571\u20131580.e3. https:\/\/doi.org\/10.1016\/j.ophtha.2008.02.026","journal-title":"Ophthalmology"},{"key":"1609_CR58","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/ijg.0b013e3181997211","volume":"18","author":"S Yazdani","year":"2009","unstructured":"Yazdani\u00a0S, Hendi\u00a0K, Pakravan\u00a0M et\u00a0al (2009) Intravitreal bevacizumab for neovascular glaucoma. J\u00a0Glaucoma 18:632\u2013637. https:\/\/doi.org\/10.1097\/ijg.0b013e3181997211","journal-title":"J Glaucoma"},{"key":"1609_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/eye.2015.259","volume":"30","author":"LC Olmos","year":"2016","unstructured":"Olmos\u00a0LC, Sayed\u00a0MS, Moraczewski\u00a0AL et al (2016) Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye (Lond) 30:463\u2013472. https:\/\/doi.org\/10.1038\/eye.2015.259","journal-title":"Eye (Lond)"},{"key":"1609_CR60","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajo.2008.11.015","volume":"147","author":"Y Takihara","year":"2009","unstructured":"Takihara\u00a0Y, Inatani\u00a0M, Fukushima\u00a0M et\u00a0al (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 147:912\u2013918.e1. https:\/\/doi.org\/10.1016\/j.ajo.2008.11.015","journal-title":"Am J Ophthalmol"},{"key":"1609_CR61","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/opth.s16976","volume":"5","author":"CC Shen","year":"2011","unstructured":"Shen\u00a0CC, Salim\u00a0S, Du\u00a0H, Netland\u00a0PA (2011) Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma. Clin Ophthalmol 5:281\u2013286. https:\/\/doi.org\/10.2147\/opth.s16976","journal-title":"Clin Ophthalmol"},{"key":"1609_CR62","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1442-9071.2010.02285.x","volume":"38","author":"S Ghosh","year":"2010","unstructured":"Ghosh\u00a0S, Singh\u00a0D, Ruddle\u00a0JB et\u00a0al (2010) Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Exp Ophthalmol 38:353\u2013357. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02285.x","journal-title":"Clin Exp Ophthalmol"},{"key":"1609_CR63","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1136\/bjo.2007.116533","volume":"91","author":"ME Iliev","year":"2007","unstructured":"Iliev\u00a0ME, Gerber\u00a0S (2007) Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 91:1631\u20131635. https:\/\/doi.org\/10.1136\/bjo.2007.116533","journal-title":"Br J Ophthalmol"},{"key":"1609_CR64","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1136\/bjo.87.10.1252","volume":"87","author":"CC Murphy","year":"2003","unstructured":"Murphy\u00a0CC, Burnett\u00a0CAM, Spry\u00a0PGD et al (2003) A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 87:1252. https:\/\/doi.org\/10.1136\/bjo.87.10.1252","journal-title":"Br J Ophthalmol"},{"key":"1609_CR65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/ijg.0b013e31817d235c","volume":"18","author":"N Yildirim","year":"2009","unstructured":"Yildirim\u00a0N, Yalvac\u00a0IS, Sahin\u00a0A et\u00a0al (2009) A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma. J\u00a0Glaucoma 18:192\u2013196. https:\/\/doi.org\/10.1097\/ijg.0b013e31817d235c","journal-title":"J Glaucoma"},{"key":"1609_CR66","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.12688\/f1000research.26879.2","volume":"9","author":"P Strzalkowski","year":"2020","unstructured":"Strzalkowski\u00a0P, Strzalkowska\u00a0A, G\u00f6bel\u00a0W et al (2020) Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma \u2014 a\u00a0retrospective interventional case series. F1000Res 9:1236. https:\/\/doi.org\/10.12688\/f1000research.26879.2","journal-title":"F1000Res"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01609-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-022-01609-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-022-01609-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T09:08:08Z","timestamp":1649754488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-022-01609-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1609"],"URL":"https:\/\/doi.org\/10.1007\/s00347-022-01609-3","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"22 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>R.\u00a0Greslechner:<\/b> A.\u00a0Finanzielle Interessen: R.\u00a0Greslechner gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter Arzt, Universit\u00e4tsklinikum Regensburg (Oberarzt Augenklinik)\u00a0| Mitgliedschaften: Deutsche Ophthalmologische Gesellschaft, \u00d6sterreichische Ophthalmologische Gesellschaft. <b>H.\u00a0Helbig:<\/b> A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung von BMBF, Jackst\u00e4dt-Stiftung, Velux Stiftung, Novartis Pharma, DFG f\u00fcr Forschungsvorhaben des Lehrstuhls, nicht zur freien pers\u00f6nlichen Verf\u00fcgung.\u00a0\u2013 Vortragshonorare und Reisekostenerstattung: Novartis, Bayer, Allergan, Alimera, Alcon, Apellis, Roche.\u00a0\u2013 Advisory board f\u00fcr: Allergan, Bayer, ImplantData, Th\u00e9a Pharma, Apellis, Roche und Novartis.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Angestellter am UKR\u00a0| Vorstand RG, Pressesprecher DOG\u00a0| Mitgliedschaften: DOG, RG, BVA, ARVO, AAO, Euretina, DHV\u00a0| H.\u00a0Helbig ist Mitglied des Herausgeberboards von <i>Der Ophthalmologe<\/i>. Er war nicht an der Begutachtung dieses Manuskripts durch die Zeitschrift oder an Entscheidungen in Bezug auf dieses Manuskript beteiligt. <b>D.\u00a0Spiegel:<\/b> A.\u00a0Finanzielle Interessen: D.\u00a0Spiegel gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Niedergelassener Augenarzt (Augenzentrum M\u00fcnchen S\u00fcd); Konsiliararzt (Universit\u00e4tsklinikum Regensburg).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}